FIELD: medicine. SUBSTANCE: preparation has components at the following doses: interferon 500000 IU; alpha-tocopherol acetate 0.01-0.2 g as an antioxidant. Preparation is made as rectal gelatin capsule or suppository and administrated by rectal route. EFFECT: simplified treatment, high antiviral and antiinfectious activity. 3 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL PREPARATION FOR VIRAL INFECTION TREATMENT | 1992 |
|
RU2097061C1 |
| RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
| ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
| CURATIVE AGENT | 2000 |
|
RU2187332C1 |
| RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 |
|
RU2150291C1 |
| PREPARATION FOR TREATING INFLAMMATORY DISEASES | 2000 |
|
RU2170101C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
| IMPROVED MEDICINAL FORM OF HUMAN INTERFERON: SUPPOSITORY | 1997 |
|
RU2148988C1 |
| RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
Authors
Dates
1996-04-10—Published
1992-02-11—Filed